Drug intelligence / Profile preview

bifidobacterium + lactobacillus + glutamine

Development stage: Unknown
Lead developer: West China Hospital of Sichuan University
Modality: Small Molecules, Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Bifidobacterium + lactobacillus combined with compound glutamine is an investigational combination therapy consisting of live probiotic bacteria and the amino acid glutamine. It is being evaluated in a Phase 2/3 clinical trial (NCT05406882) by West China Hospital for the prevention and treatment of radiation proctitis in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy. The probiotic component (Bifidobacterium and Lactobacillus) aims to restore and maintain a healthy gut microbiota balance, while the glutamine component supports the integrity and repair of the intestinal mucosal barrier, which is frequently damaged during pelvic radiation therapy.

Brand names: DS-01 Daily SynbioticDS01 Daily SynbioticDS 01 Daily SynbioticLTH Balance Multi Pro 30B ProbioticIsomaxPrisma Natural Glutamine and Probiotic
Other names: live bifidobacterium and lactobacillus tablets combined with compound glutamine enteric-coated capsulesprobiotics and glutamine

Beyond the preview

Go deeper on bifidobacterium + lactobacillus + glutamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bifidobacterium + lactobacillus + glutamine.

Explore the full profile